The person who sent the message was none other than Wei Liqun, chairman of Chenghuang Company!
Wei Liqun: "Boss! The results of Song He Su's preclinical trials are out. They're perfect, with an efficacy rate approaching one hundred percent!"
Wei Liqun sent over an attachment. Song He opened it and found a detailed set of preclinical trial data.
The data at the beginning covered the usual items: molecular formula, purity, the ADME process, elimination half-life, toxicity potential, drug interactions, and so on.
Song He skimmed through it. There were absolutely no problems. Some of the indicators had even far exceeded his expectations!
He focused on the final section of data: the animal experiments!
For ordinary new-drug experiments, only one rodent species and one non-rodent species were generally selected.
However, Song He Su was clearly no ordinary drug, so the experimental process was also more rigorous. Rats, mice, pigs, dogs, and monkeys—five animal species in total—were selected!
Multiple breeds were deliberately chosen for each species as well. For example, besides the internationally common Gottingen Minipig, the experimental pigs also included Wuzhi Mountain, Banna, and Bama Pig!
A large number of animals with special conditions were used as well, including Spontaneously Hypertensive Rat SHR, KKAy mice with spontaneous type 2 diabetes, pregnant mice, and others!
Thus, a long list of animal experiment data appeared.
With such a demanding experimental standard, most new-drug developers would probably be sweating bullets.
Fortunately, Song He Su's quality was beyond reproach!
Song He carefully read through the experimental data for each animal species, the corners of his mouth curling into an uncontrollable smile!
Song He Su had an extremely high efficacy rate in animals, with effects that could practically be described as curing illnesses the moment it was administered! At the same time, whether liver toxicity, kidney